Joniau S - Search Results

1

De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N, Spahn M, Mareel M. De Meerleer G, et al. Among authors: joniau s. Lancet Oncol. 2014 Apr;15(4):e170-7. doi: 10.1016/S1470-2045(13)70569-2. Lancet Oncol. 2014. PMID: 24694640 Review.

2

Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy.

Goeman L, Joniau S, Oyen R, Van Poppel H. Goeman L, et al. Among authors: joniau s. Urology. 2006 Jan;67(1):199. doi: 10.1016/j.urology.2005.07.039. Urology. 2006. PMID: 16413367

3

The indications for partial nephrectomy in the treatment of renal cell carcinoma.

Joniau S, Vander Eeckt K, Van Poppel H. Joniau S, et al. Nat Clin Pract Urol. 2006 Apr;3(4):198-205. doi: 10.1038/ncpuro0458. Nat Clin Pract Urol. 2006. PMID: 16607368 Review.

4

Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b).

Klaver S, Joniau S, Suy R, Oyen R, Van Poppel H. Klaver S, et al. Among authors: joniau s. BJU Int. 2008 Feb;101(4):444-9. doi: 10.1111/j.1464-410X.2007.07257.x. Epub 2007 Nov 16. BJU Int. 2008. PMID: 18021278

5

Outcome of nephron-sparing surgery for T1b renal cell carcinoma.

Joniau S, Vander Eeckt K, Srirangam SJ, Van Poppel H. Joniau S, et al. BJU Int. 2009 May;103(10):1344-8. doi: 10.1111/j.1464-410X.2008.08230.x. Epub 2008 Nov 25. BJU Int. 2009. PMID: 19040528

6

Open to debate. The motion: Nomograms should become a routine tool in determining prostate cancer prognosis.

Briganti A, Karakiewicz PI, Joniau S, Van Poppel H. Briganti A, et al. Among authors: joniau s. Eur Urol. 2009 Mar;55(3):743-7. doi: 10.1016/j.eururo.2008.11.038. Epub 2008 Dec 4. Eur Urol. 2009. PMID: 19081177 No abstract available.

7

Vaccine therapy in patients with renal cell carcinoma.

Van Poppel H, Joniau S, Van Gool SW. Van Poppel H, et al. Among authors: joniau s. Eur Urol. 2009 Jun;55(6):1333-42. doi: 10.1016/j.eururo.2009.01.043. Epub 2009 Jan 30. Eur Urol. 2009. PMID: 19201522 Review.

8

Words of wisdom. Re: Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.

Joniau S, Spahn M. Joniau S, et al. Eur Urol. 2011 Nov;60(5):1121-2. doi: 10.1016/j.eururo.2011.08.034. Eur Urol. 2011. PMID: 21961741 No abstract available.

9

Sense and nonsense of an extended pelvic lymph node dissection in prostate cancer.

Van Baelen A, Mottet N, Spahn M, Briganti A, Gontero P, Joniau S. Van Baelen A, et al. Among authors: joniau s. Adv Urol. 2012;2012:983058. doi: 10.1155/2012/983058. Epub 2011 Oct 9. Adv Urol. 2012. PMID: 22007203 Free PMC article.

10

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.

Briganti A, Joniau S, Gontero P, Abdollah F, Passoni NM, Tombal B, Marchioro G, Kneitz B, Walz J, Frohneberg D, Bangma CH, Graefen M, Tizzani A, Frea B, Karnes RJ, Montorsi F, Van Poppel H, Spahn M. Briganti A, et al. Among authors: joniau s. Eur Urol. 2012 Mar;61(3):584-92. doi: 10.1016/j.eururo.2011.11.043. Epub 2011 Dec 2. Eur Urol. 2012. PMID: 22153925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

434 results

Search Page